Related Experiment Video
Updated: May 26, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
Published on: July 7, 2023
[Can we identify biomarkers in bipolar depression? From imaging to biology]
1Université Paris-Est, faculté de médecine, UMR-S 955, Créteil, F-94010, France. marion.leboyer@inserm.fr
Abstract:
Biomarkers can be used to describe and quantify a biological process related to pathology or to the effect of a treatment. In bipolar depression, progresses in the fields of structural and functional imaging, but also in biological research help to identify such biomarkers. Results in structural imaging are heterogeneous. Using functional imaging, in bipolar depression we can identify an hyperactivity of limbic and striatal regions with a specific implication of the lateral part of the orbito-frontal cortex. Bipolar depression is also associated with a modification of neurotrophic factors and of factors involved in the inflammatory process. Modifications in circadian rhythms have also be described but their level of specificity have to be demonstrated. The identification of biomarkers for bipolar depression seems to be an interesting field, but it still remains in the domain of research.
Related Concept Videos
Bipolar Disorder
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Depression: Overview
Mania and Antimanic Drugs: Overview

